Evidence map›Paper›PMID 31091473›Full record

ArticleActa biomaterialia2019

Graphene oxide containing self-assembling peptide hybrid hydrogels as a potential 3D injectable cell delivery platform for intervertebral disc repair applications.

Cosimo Ligorio, Mi Zhou, Jacek K Wychowaniec, Xinyi Zhu, Cian Bartlam, Aline F Miller, Aravind Vijayaraghavan, Judith A Hoyland, Alberto Saiani

Open access · hybridAbstract read
In one paragraph

Article in Acta biomaterialia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. RGD-functionalised self-assembling peptide hydrogel induces a proliferative profile in human osteoblasts in vitro.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  8. Tissue engineering strategies for treating intervertebral disc degeneration.Frontiers in bioengineering and biotechnology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. [Physicochemical properties of a novel chiral self-assembling peptide R-LIFE-1 and its controlled release to exosomes].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cosimo LigorioSchool of Materials, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; Manchester Institute of Biotechnology (MIB), The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Mi ZhouSchool of Materials, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; Manchester Institute of Biotechnology (MIB), The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Jacek K WychowaniecSchool of Materials, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; Manchester Institute of Biotechnology (MIB), The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Xinyi ZhuManchester Institute of Biotechnology (MIB), The University of Manchester, Oxford Road, Manchester M13 9PL, UK; School of Chemical Engineering and Analytical Sciences, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Cian BartlamSchool of Materials, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Aline F MillerManchester Institute of Biotechnology (MIB), The University of Manchester, Oxford Road, Manchester M13 9PL, UK; School of Chemical Engineering and Analytical Sciences, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Aravind VijayaraghavanSchool of Materials, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; National Graphene Institute (NGI), The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Judith A HoylandDivision of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Grafton St, M13 9WU Manchester, UK.
Alberto SaianiSchool of Materials, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; Manchester Institute of Biotechnology (MIB), The University of Manchester, Oxford Road, Manchester M13 9PL, UK. Electronic address: a.saiani@manchester.ac.uk.
University of Manchester · GBManchester Academic Health Science Centre · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

Cell-based therapies have shown significant promise in tissue engineering with one key challenge being the delivery and retention of cells. As a result, significant efforts have been made in the past decade to design injectable biomaterials to host and deliver cells at injury sites. Intervertebral disc (IVD) degeneration, a major cause of back pain, is a particularly relevant example where a minimally-invasive cellular therapy could bring significant benefits specifically at the early stages of the disease, when a cell-driven process starts in the gelatinous core of the IVD, the nucleus pulposus (NP). In this present study we explore the use of graphene oxide (GO) as nano-filler for the reinforcement of FEFKFEFK (β-sheet forming self-assembling peptide) hydrogels. Our results confirm the presence of strong interactions between FEFKFEFK and GO flakes with the peptide coating and forming short thin fibrils on the surface of the flakes. These strong interactions were found to affect the bulk properties of hybrid hydrogels. At pH 4 electrostatic interactions between the peptide fibres and the peptide-coated GO flakes are thought to govern the final bulk properties of the hydrogels while at pH 7, after conditioning with cell culture media, electrostatic interactions are removed leaving the hydrophobic interactions to govern hydrogel final properties. The GO-F820 hybrid hydrogel, with mechanical properties similar to the NP, was shown to promote high cell viability and retained cell metabolic activity in 3D over the 7 days of culture and therefore shown to harbour significant potential as an injectable hydrogel scaffold for the in-vivo delivery of NP cells. STATEMENT OF SIGNIFICANCE: Short self-assembling peptide hydrogels (SAPHs) have attracted significant interest in recent years as they can mimic the natural extra-cellular matrix, holding significant promise for the ab initio design of cells' microenvironments. Recently the design of hybrid hydrogels for biomedical applications has been explored through the incorporation of specific nanofillers. In this study we exploited graphene oxide (GO) as nanofiller to design hybrid injectable 3Dscaffolds for the delivery of nucleus pulposus cells (NPCs) for intervertebral disc regeneration. Our work clearly shows the presence of strong interactions between peptide and GO, mimicking the mechanical properties of the NP tissue and promoting high cell viability and metabolic activity. These hybrid hydrogels therefore harbour significant potential as injectable scaffolds for the in vivo delivery of NPCs.

Indexed as

InjectionsAmino Acid SequenceAnimalsCattleCell SurvivalGraphiteHydrogelsIntervertebral DiscPeptidesRegenerationTissue Engineeringgraphene oxideGraphiteHydrogelsPeptidesCell cultureCell deliveryGraphene oxideHydrogelsInjectableNucleus pulposusPeptideTissue engineering

Identifiers

PMID31091473
PMCPMC6582688
OpenAlexW2944409985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.